Geert van Amerongen

14.5k citations

160 papers · 9.4k indexed · 1 hit paper · h-index 50

Infectious Diseases top 0.1%
- Viral Infections and Vectors 27
- SARS-CoV-2 and COVID-19 Research 23
- Viral gastroenteritis research and epidemiology 22
Virology top 0.5%
Epidemiology top 0.2%
- Respiratory viral infections research 78
- Influenza Virus Research Studies 68
- Virology and Viral Diseases 33
Agronomy and Crop Science top 0.2%
- Animal Disease Management and Epidemiology 24
Animal Science and Zoology top 0.2%
Immunology
- Immune Response and Inflammation 18

Co-authors: Albert D. M. E. Osterhaus Thijs Kuiken Ron A. M. Fouchier Guus F. Rimmelzwaan Rik L. de Swart Koert J. Stittelaar Debby van Riel Theo M. Bestebroer
Cited by: Infectious Diseases Virology Epidemiology
Journals: Vaccine (34 papers)Journal of Virology (21 papers)Journal of General Virology (11 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Geert van Amerongen

155 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Geert van Amerongen

Since Specialization

Citations

This map shows the geographic impact of Geert van Amerongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert van Amerongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert van Amerongen more than expected).

Fields of papers citing papers by Geert van Amerongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert van Amerongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert van Amerongen. The network helps show where Geert van Amerongen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Geert van Amerongen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Geert van Amerongen Line = papers co-authored together Geert van Amerongen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Syrian hamsters (Mesocricetus auratus) as an upper respiratory tract model for respiratory syncytial virus infection PubMed ·yuanzhi He,Kate Guilfoyle,Paul TRIO,Geert van Amerongen,脱凡,中野義明,Wolfgang Baumgärtner,Martin Ludlow,Albert Osterhaus	2025	0
2	Highly Pathogenic Avian Influenza Virus A/H5N1 Subclade 2.3.4.4b Isolated from a European Grey Seal ( Halichoerus grypus ) Is Highly Virulent in Ferrets The Journal of Infectious Diseases ·Kate Guilfoyle,Alberto Ramírez,Leon de Waal,Geert van Amerongen,脱凡,Theresa Störk,Luciana Marques Meireles,Wolfgang Baumgärtner,Ásgeir Bjarnason,Susumu Okamura,Guus F. Rimmelzwaan,Martin Ludlow,Albert Osterhaus	2025	1
3	Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits Viruses ·W. Widagdo,Nisreen M.A. Okba,Mathilde Richard,Dennis de Meulder,Theo M. Bestebroer,Pascal Lexmond,Elmoubasher Farag,Zhong Guo,Koert J. Stittelaar,Leon de Waal,Geert van Amerongen,Judith M. A. van den Brand,Bart L. Haagmans,Sander Herfst	2019	10
4	Analysis of Mouse Brain Transcriptome After Experimental Duvenhage Virus Infection Shows Activation of Innate Immune Response and Pyroptotic Cell Death Pathway Frontiers in Microbiology ·Penelope Koraka,B Martina,Henk‐Jan van den Ham,Fatiha Zaaraoui‐Boutahar,Wilfred F. J. van IJcken,Anelisie da Silva Santos,Geert van Amerongen,Arno C. Andeweg,Esther J Ehrman	2018	10
5	Vaccination Is More Effective Than Prophylactic Oseltamivir in Preventing CNS Invasion by H5N1 Virus via the Olfactory Nerve The Journal of Infectious Diseases ·Jurre Y. Siegers,Ted Di Maria,Lonneke Leijten,智美清水,Adelina Eugenia Ivanov,Geert van Amerongen,Koert J. Stittelaar,Marion Koopmans,Albert D. M. E. Osterhaus,Thijs Kuiken,Debby van Riel	2016	11
6	Long-Term Effect of Serial Infections with H13 and H16 Low-Pathogenic Avian Influenza Viruses in Black-Headed Gulls Journal of Virology ·Josanne H. Verhagen,Úrsula Höfle,Geert van Amerongen,Marco van de Bildt,Frank A Majoor,Ron A. M. Fouchier,Thijs Kuiken	2015	32
7	Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Ronan MacLoughlin,Geert van Amerongen,James B. Fink,Hettie M. Janssens,W. Paul Duprex,Rik L. de Swart	2015	16
8	Modification of the Ferret Model for Pneumonia From Seasonal Human Influenza A Virus Infection Veterinary Pathology ·Judith M. A. van den Brand,Koert J. Stittelaar,Lonneke Leijten,Geert van Amerongen,James H. Simon,Albert D. M. E. Osterhaus,Thijs Kuiken	2012	24
9	Simian varicella virus infection of Chinese rhesus macaques produces ganglionic infection in the absence of rash Journal of NeuroVirology ·Werner J. D. Ouwendijk,Ravi Mahalingam,Vicki Traina‐Dorge,Geert van Amerongen,Mary Wellish,Albert D. M. E. Osterhaus,Don Gilden,Georges M. G. M. Verjans	2012	16
10	Early Target Cells of Measles Virus after Aerosol Infection of Non-Human Primates PLoS Pathogens ·Ken Lemon,Rory D. de Vries,Annelies W. Mesman,Stephen McQuaid,Geert van Amerongen,Selma Yüksel,Martin Ludlow,Linda J. Rennick,Thijs Kuiken,Bertus K. Rima,Teunis B. H. Geijtenbeek,Albert D. M. E. Osterhaus,W. Paul Duprex,Rik L. de Swart	2011	169
11	Distinct Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury Pathways in Two Different Nonhuman Primate Species Journal of Virology ·Saskia L. Smits,Judith M. A. van den Brand,Túlia Fernanda Meira Garcia,Lonneke Leijten,Wilfred F. J. van IJcken,Geert van Amerongen,Albert D. M. E. Osterhaus,Arno C. Andeweg,Bart L. Haagmans	2011	58
12	Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets Vaccine ·Benoı̂t Baras,Leon de Waal,Koert J. Stittelaar,Abu baker Ahmed Siddig,Sandra L. Giannini,Edwin J. B. Veldhuis Kroeze,Judith M. A. van den Brand,Geert van Amerongen,James H. Simon,Emmanuel Hanon,Sally Mossman,Albert D. M. E. Osterhaus	2011	22
13	Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model Journal of General Virology ·Joost H. C. M. Kreijtz,Ходин Виктор Владимирович,Rogier Bodewes,Astrid Schwantes,Geert van Amerongen,R. Joyce Verburgh,Gerrie de Mutsert,Judith M. A. van den Brand,Stella E. van Trierum,Thijs Kuiken,Ron A. M. Fouchier,Albert D. M. E. Osterhaus,Gerd Sutter,Guus F. Rimmelzwaan	2010	35
14	Experimental Pandemic (H1N1) 2009 Virus Infection of Cats Emerging infectious diseases ·Judith M. A. van den Brand,Koert J. Stittelaar,Geert van Amerongen,Marco W. G. van de Bildt,Lonneke Leijten,Thijs Kuiken,Albert D. M. E. Osterhaus	2010	27
15	Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates PLoS Pathogens ·Saskia L. Smits,Túlia Fernanda Meira Garcia,Judith M. A. van den Brand,Lonneke Leijten,Wilfred F. J. van IJcken,Marinus J.C. Eijkemans,Geert van Amerongen,Thijs Kuiken,Arno C. Andeweg,Albert D. M. E. Osterhaus,Bart L. Haagmans	2010	270
16	Highly Pathogenic Avian Influenza Virus H7N7 Isolated From a Fatal Human Case Causes Respiratory Disease in Cats but Does Not Spread Systemically American Journal Of Pathology ·Debby van Riel,Guus F. Rimmelzwaan,Geert van Amerongen,Albert D. M. E. Osterhaus,Thijs Kuiken	2010	32
17	Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques The Journal of Infectious Diseases ·Joost H. C. M. Kreijtz,Yasemin Suezer,Gerrie de Mutsert,Judith M. A. van den Brand,Geert van Amerongen,Barbara S. Schnierle,Thijs Kuiken,Ron A. M. Fouchier,Johannes Löwer,Albert D. M. E. Osterhaus,Gerd Sutter,Guus F. Rimmelzwaan	2008	64
18	Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection Nature ·Koert J. Stittelaar,Johan Neyts,Lieve Naesens,Geert van Amerongen,Takahito Matsushima,Antonı́n Holý,Erik De Clercq,Hubert G.M. Niesters,Edwin Fries,H. H. Steenfos,Paul Mulder,B A van der Zeijst,Albert D. M. E. Osterhaus	2005	166
19	Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus Journal of Virology ·Koert J. Stittelaar,Geert van Amerongen,Ivanela Kondova,Thijs Kuiken,Takahito Matsushima,F.H.M. Pistoor,Hubert G.M. Niesters,Gerard van Doornum,B A van der Zeijst,Luis Mateo,Paul Chaplin,Albert D. M. E. Osterhaus	2005	170
20	Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology Vaccine ·Leon de Waal,Linda S. Wyatt,Selma Yüksel,Geert van Amerongen,Bernard Moss,Hubert G.M. Niesters,Albert D. M. E. Osterhaus,Rik L. de Swart	2003	28

About Geert van Amerongen

Geert van Amerongen is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 160 papers that have together received 9.4k indexed citations. Recurring topics across this work include Respiratory viral infections research (78 papers), Influenza Virus Research Studies (68 papers), Virology and Viral Diseases (33 papers), Viral Infections and Vectors (27 papers), Animal Disease Management and Epidemiology (24 papers), SARS-CoV-2 and COVID-19 Research (23 papers), Viral gastroenteritis research and epidemiology (22 papers) and Immune Response and Inflammation (18 papers). The work is most often cited by research in Infectious Diseases (4.8k citations), Virology (1.1k citations) and Epidemiology (5.8k citations). Geert van Amerongen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Albert D. M. E. Osterhaus, Thijs Kuiken, Ron A. M. Fouchier, Guus F. Rimmelzwaan, Rik L. de Swart, Koert J. Stittelaar, Debby van Riel, Theo M. Bestebroer, Bart L. Haagmans and Judith M. A. van den Brand. Their work appears in journals such as Vaccine, Journal of Virology, Journal of General Virology, The Journal of Infectious Diseases and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact